About Calsequestrin-2
Calsequestrin-2 (CASQ2) is a protein
from Homo sapiens identified by UniProt accession
O14958, 399 residues long.
MolForge cross-references it against 0 known binders and
246 disease associations.
Target properties
| Protein name | Calsequestrin-2 |
| UniProt accession | O14958 |
| Gene | CASQ2 |
| Organism | Homo sapiens |
| Length | 399 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (246)
Diseases linked to this target (Open Targets).
- catecholaminergic polymorphic ventricular tachycardia · score 0.72
- catecholaminergic polymorphic ventricular tachycardia 1 · score 0.59
- Abnormality of the cardiovascular system · score 0.54
- electrocardiography · score 0.49
- atrial fibrillation · score 0.44
- QRS duration · score 0.42
- pulse pressure measurement · score 0.39
- neurodegenerative disease · score 0.30
- heart function measurement · score 0.30
- Prolonged QT interval · score 0.30
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-O14958-F1 | alphafold | PREDICTED | 90.51 | — |
Amino-acid sequence (399 residues)
MKRTHLFIVG IYFLSSCRAE EGLNFPTYDG KDRVVSLSEK NFKQVLKKYD LLCLYYHEPV SSDKVTQKQF QLKEIVLELV AQVLEHKAIG FVMVDAKKEA KLAKKLGFDE EGSLYILKGD RTIEFDGEFA ADVLVEFLLD LIEDPVEIIS SKLEVQAFER IEDYIKLIGF FKSEDSEYYK AFEEAAEHFQ PYIKFFATFD KGVAKKLSLK MNEVDFYEPF MDEPIAIPNK PYTEEELVEF VKEHQRPTLR RLRPEEMFET WEDDLNGIHI VAFAEKSDPD GYEFLEILKQ VARDNTDNPD LSILWIDPDD FPLLVAYWEK TFKIDLFRPQ IGVVNVTDAD SVWMEIPDDD DLPTAEELED WIEDVLSGKI NTEDDDEDDD DDDNSDEEDN DDSDDDDDE
Explore Calsequestrin-2 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets